Data vs opinion, phenytoin vs fosphenytoin: The saga continues

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2631-2632
Number of pages2
JournalArchives of Internal Medicine
Volume159
Issue number22
DOIs
StatePublished - Dec 27 1999

Fingerprint

Consensus Development Conferences
Drug Industry
Phenytoin
Anticonvulsants
Seizures
Safety
fosphenytoin

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Data vs opinion, phenytoin vs fosphenytoin : The saga continues. / Labiner, David M.

In: Archives of Internal Medicine, Vol. 159, No. 22, 27.12.1999, p. 2631-2632.

Research output: Contribution to journalArticle

@article{d87c5f2c1c5d4bb4b138b0973091348d,
title = "Data vs opinion, phenytoin vs fosphenytoin: The saga continues",
author = "Labiner, {David M}",
year = "1999",
month = "12",
day = "27",
doi = "10.1001/archinte.159.22.2631",
language = "English (US)",
volume = "159",
pages = "2631--2632",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "22",

}

TY - JOUR

T1 - Data vs opinion, phenytoin vs fosphenytoin

T2 - The saga continues

AU - Labiner, David M

PY - 1999/12/27

Y1 - 1999/12/27

UR - http://www.scopus.com/inward/record.url?scp=0033611313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033611313&partnerID=8YFLogxK

U2 - 10.1001/archinte.159.22.2631

DO - 10.1001/archinte.159.22.2631

M3 - Article

C2 - 10597752

AN - SCOPUS:0033611313

VL - 159

SP - 2631

EP - 2632

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 22

ER -